Executive Director, Haematology, International Commercial Launch Strategy

Novartis Pharma Schweiz AG seeks an Executive Director for Haematology International Commercial Launch Strategy in Basel. This senior role leads global launch strategy for a transformative blood disorder treatment, combining scientific and commercial expertise.

The company is looking for a senior leader to direct the international commercial launch strategy for a key treatment in blood disorders such as CML or MF. This position merges deep scientific understanding with commercial acumen to drive timely market entry and sustainable growth. The role focuses on strategic decision-making, integrating market insights, and fostering innovative approaches to expand patient access while strengthening the company's position in haematology.

Responsibilities

• Develop the international launch strategy for a leading CML or MF therapy, ensuring it aligns with haematology goals and patient requirements.
• Foster collaboration across medical, regulatory, access, commercial, and supply teams to ensure effective execution.
• Prepare priority markets for launch by identifying potential risks early and developing practical mitigation strategies.
• Leverage market insights, competitive intelligence, and stakeholder feedback to refine global positioning and messaging.
• Work with regional and country teams to support local execution while maintaining alignment with the global strategy.
• Define, monitor, and govern critical launch milestones and performance indicators to support timely, evidence-based decisions.
• Communicate clearly with senior leaders on vision, progress, and strategic priorities across international markets.
• Promote strong standards of compliance, operational excellence, and best practice in launch execution.
• Contribute to development planning by helping shape target product profiles and evidence needs that support market access potential.
• Lead commercial excellence initiatives and strengthen customer-centred engagement approaches across regions.

Requirements

• Recent, significant Profit and Loss (P&L) leadership experience at country level.
• Approximately 15 years of progressive commercial experience across country and above‑country roles.
• Proven success leading launches and shaping therapeutic area strategy across diverse international markets.
• Strong understanding of hematology or related specialty areas, with experience translating scientific insights into strategic plans.
• Demonstrated ability to lead in complex, fast‑evolving environments and deliver results across high‑growth markets.
• Expertise in turning scientific data into differentiated value propositions across pre‑launch and lifecycle management phases.
• Consistent record of influencing cross-unit and cross-functional teams to achieve shared strategic goals.
• Ability to integrate multiple market insights and stakeholder perspectives to guide clear, evidence-based decision-making.

Nice to have

• Proven ability to lead and inspire diverse, cross-regional teams, fostering collaboration, clarity, and strategic alignment across complex environments.
• Demonstrated strength in influencing senior stakeholders and navigating matrixed structures to drive shared priorities and long-term business impact.

What the company offers

• Expected Annual Base Salary Range: 169,400.00 - 314,600.00 CHF.
• Eligible for a performance-based bonus depending on certain performance parameters.
• Competitive benefits in kind including insurance plans, retirement plans, wellbeing resources and global recognition programs.
• Flexible and hybrid working options, where possible.
• Minimum 14 weeks paid parental leave.

About the company

Novartis Pharma Schweiz AG is committed to reimagining medicine together and rewarding the people who make it happen.

• Committed to reimagining medicine together and rewarding the people who make it happen.